ESC Premium Access

Percutaneous left atrial appendage closure and conservative antithrombotic treatment in patients with atrial fibrillation and contraindication to oral anticoagulation: a 5-year follow-up study

Topic: Left Atrial Appendage (LAA) Closure

Congress Presentation

About the speaker

Mr Jussi-Pekka Johannes Pouru

Turku University Hospital, Turku (Finland)
0 follower

15 more presentations in this session

Myocardial injury during TAVI with self-expanding prosthesis is not associated with patient-prosthesis features, hemodynamics or clinical outcome

Speaker: Doctor M. Johnsen (Oslo, NO)

Thumbnail

Cerebral near-infrared spectroscopy monitoring during transcatheter aortic valve implantation

Speaker: Doctor P. Seppelt (Frankfurt, DE)

Thumbnail

Clinical and echocardiographic outcomes after treatment of patent foramen ovale with two transcatheter occlusion devices: mononcenter observational study

Speaker: Mr M. Alsaad (Bielefeld, DE)

Thumbnail

Platelet reactivity changes following transcatheter aortic valve implantation

Speaker: Doctor Z. Ostojic (Zagreb, HR)

Thumbnail

Impact of frailty status on 30-day mortality in patients with valvular heart disease undergoing percutaneous transcatheter valve interventions

Speaker: Doctor B. Al-Kassou (Bonn, DE)

Thumbnail

Access the full session

Poster Session 4 - Non-coronary cardiac intervention

Speakers: Mr J. Pouru, Doctor M. Johnsen, Doctor P. Seppelt, Mr M. Alsaad, Doctor Z. Ostojic...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb